tirzepatide on medicaid Coverage of and Spending GLP-1s Why Medicare Won't Cover GLP-1

However, this should always follow medical review and clinician approval

Clinical studies show: Mounjaro (tirzepatide) can help patients lose up to 22% of their body weight on average over 72 weeks Wegovy (semaglutide) produces an average 17% weight loss after 68 weeks under medical supervision Bariatric surgery such as a gastric sleeve or bypass can sometimes result in up to 70% total body weight loss within 1 to 2 years, but this depends on post-surgery lifestyle choices

A typical taper involves gradually reducing your dose over four to eight weeks before stopping completely

Were talking up to 1520% of total body weight in clinical studies

This guide breaks down the testing data, the availability timeline, the quality concerns, and the alternatives